Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1000275 TORONTO, A6
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,533,496
-$1,433,932 QoQ
Shares Held
139,664
-37.4% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. ACAD ranks #39 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in ACAD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,533,496 139,664
2026-03-31 $4,967,428 223,155
2025-12-31 $7,768,709 290,854
2025-09-30 $19,215,088 900,426
2025-06-30 $1,263,072 58,557
2025-03-31 $1,337,567 80,528
2024-12-31 $847,329 46,176
2024-09-30 $831,688 54,076
2024-06-30 $807,413 49,687
2024-03-31 $762,230 41,224
2023-12-31 $2,117,806 67,640
2023-09-30 $1,183,669 56,798
2023-06-30 $1,257,899 52,522
2023-03-31 $932,831 49,566
2022-12-31 $1,143,069 71,801
2022-09-30 $1,149,974 70,292
2022-06-30 $1,111,656 78,897
2022-03-31 $1,880,318 77,635
2021-12-31 $2,218,301 95,043
2021-09-30 $1,375,605 82,818
2021-06-30 $2,014,538 82,597
2021-03-31 $4,006,066 155,274
2020-12-31 $10,303,983 192,742
2020-09-30 $7,601,755 184,285
2020-06-30 $10,078,315 207,929
2020-03-31 $8,219,440 194,543